Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rift Valley Fever | 1 | 2019 | 39 | 0.77 | Why? |
| Rift Valley fever virus | 1 | 2019 | 48 | 0.77 | Why? |
| Antibodies, Neutralizing | 14 | 2021 | 25288 | 0.56 | Why? |
| Antibodies, Monoclonal | 5 | 2021 | 8041 | 0.52 | Why? |
| Virus Attachment | 5 | 2020 | 1259 | 0.50 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.50 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.46 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.46 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 10 | 2020 | 8843 | 0.46 | Why? |
| Mice, Inbred BALB C | 8 | 2021 | 5814 | 0.46 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.40 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2017 | 830 | 0.39 | Why? |
| Crystallography, X-Ray | 5 | 2020 | 2689 | 0.37 | Why? |
| Spike Glycoprotein, Coronavirus | 13 | 2021 | 37182 | 0.32 | Why? |
| Dipeptidyl Peptidase 4 | 4 | 2020 | 1061 | 0.31 | Why? |
| Antibodies, Viral | 13 | 2021 | 51949 | 0.31 | Why? |
| Viral Envelope Proteins | 5 | 2021 | 3539 | 0.28 | Why? |
| Receptors, Virus | 8 | 2020 | 5659 | 0.27 | Why? |
| Viral Vaccines | 8 | 2020 | 7560 | 0.26 | Why? |
| Binding, Competitive | 2 | 2020 | 264 | 0.25 | Why? |
| Protein Binding | 12 | 2021 | 11430 | 0.24 | Why? |
| Protein Domains | 7 | 2021 | 6563 | 0.24 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.24 | Why? |
| Mice | 11 | 2021 | 21357 | 0.23 | Why? |
| Crystallization | 2 | 2020 | 331 | 0.22 | Why? |
| Animals | 23 | 2021 | 78931 | 0.22 | Why? |
| Zika Virus | 3 | 2019 | 1924 | 0.22 | Why? |
| Haplorhini | 1 | 2021 | 307 | 0.21 | Why? |
| Cell Line | 7 | 2021 | 12040 | 0.21 | Why? |
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2019 | 11 | 0.20 | Why? |
| T-Lymphocytes, Cytotoxic | 2 | 2017 | 552 | 0.20 | Why? |
| Virus Internalization | 5 | 2020 | 7921 | 0.20 | Why? |
| Poxviridae | 1 | 2019 | 23 | 0.20 | Why? |
| 4-1BB Ligand | 1 | 2018 | 9 | 0.20 | Why? |
| HLA-G Antigens | 1 | 2019 | 48 | 0.19 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.19 | Why? |
| Xanthomonas axonopodis | 1 | 2018 | 1 | 0.19 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2018 | 41 | 0.19 | Why? |
| Cross-Linking Reagents | 1 | 2018 | 91 | 0.18 | Why? |
| Oxadiazoles | 1 | 2018 | 41 | 0.18 | Why? |
| Immunity, Cellular | 3 | 2019 | 3614 | 0.18 | Why? |
| Enterohemorrhagic Escherichia coli | 1 | 2017 | 4 | 0.18 | Why? |
| Nectins | 1 | 2017 | 8 | 0.18 | Why? |
| Testicular Diseases | 1 | 2018 | 35 | 0.18 | Why? |
| Embryo Loss | 1 | 2017 | 5 | 0.18 | Why? |
| Pseudorabies | 1 | 2017 | 13 | 0.18 | Why? |
| HEK293 Cells | 6 | 2021 | 8394 | 0.18 | Why? |
| Herpesvirus 1, Suid | 1 | 2017 | 18 | 0.18 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2018 | 9335 | 0.17 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 59 | 0.17 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.17 | Why? |
| Models, Molecular | 7 | 2020 | 7616 | 0.17 | Why? |
| Quinazolines | 1 | 2018 | 126 | 0.17 | Why? |
| Immunoglobulin Fragments | 1 | 2016 | 78 | 0.17 | Why? |
| Vaccines, Virus-Like Particle | 2 | 2016 | 312 | 0.16 | Why? |
| Macaca fascicularis | 1 | 2021 | 1009 | 0.16 | Why? |
| Quantitative Structure-Activity Relationship | 1 | 2018 | 209 | 0.16 | Why? |
| Hemagglutinins | 1 | 2017 | 143 | 0.16 | Why? |
| Virus Activation | 1 | 2021 | 480 | 0.16 | Why? |
| Blastocyst | 1 | 2017 | 65 | 0.16 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.16 | Why? |
| Escherichia coli Proteins | 1 | 2017 | 168 | 0.16 | Why? |
| Chiroptera | 4 | 2021 | 3530 | 0.15 | Why? |
| Neutralization Tests | 2 | 2020 | 6698 | 0.15 | Why? |
| Zika Virus Infection | 3 | 2019 | 1920 | 0.15 | Why? |
| Glycosylation | 2 | 2017 | 1255 | 0.15 | Why? |
| Carcinoembryonic Antigen | 1 | 2016 | 140 | 0.15 | Why? |
| Acinetobacter Infections | 1 | 2018 | 273 | 0.15 | Why? |
| Heat-Shock Proteins | 1 | 2018 | 226 | 0.15 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.15 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.15 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2017 | 249 | 0.14 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.14 | Why? |
| Repetitive Sequences, Amino Acid | 1 | 2013 | 37 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2018 | 415 | 0.13 | Why? |
| Immunoglobulins | 1 | 2019 | 811 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Adjuvants, Immunologic | 2 | 2020 | 1709 | 0.13 | Why? |
| Immunity, Humoral | 2 | 2019 | 4849 | 0.12 | Why? |
| Testis | 1 | 2018 | 566 | 0.12 | Why? |
| Influenza in Birds | 1 | 2017 | 528 | 0.12 | Why? |
| SARS Virus | 5 | 2020 | 13021 | 0.12 | Why? |
| Glycoproteins | 1 | 2017 | 615 | 0.12 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.11 | Why? |
| Binding Sites | 3 | 2021 | 6201 | 0.11 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.11 | Why? |
| Mice, Inbred C57BL | 2 | 2021 | 5542 | 0.11 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.10 | Why? |
| Vaccines, Inactivated | 1 | 2017 | 1562 | 0.10 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.10 | Why? |
| Cryoelectron Microscopy | 1 | 2017 | 2372 | 0.10 | Why? |
| Coronaviridae Infections | 1 | 2013 | 442 | 0.10 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.09 | Why? |
| Protein Multimerization | 3 | 2021 | 1336 | 0.09 | Why? |
| Peptides | 1 | 2020 | 2513 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.09 | Why? |
| Drug Design | 2 | 2017 | 2627 | 0.09 | Why? |
| Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 11 | 0.09 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.08 | Why? |
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 27 | 0.08 | Why? |
| Viral Matrix Proteins | 2 | 2018 | 1243 | 0.08 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.08 | Why? |
| Porcine respiratory and reproductive syndrome virus | 1 | 2007 | 91 | 0.08 | Why? |
| Humans | 33 | 2021 | 930598 | 0.08 | Why? |
| Coronavirus | 5 | 2018 | 18339 | 0.08 | Why? |
| Species Specificity | 2 | 2021 | 1356 | 0.08 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
| Influenza A virus | 1 | 2017 | 2234 | 0.07 | Why? |
| Amino Acid Motifs | 2 | 2017 | 620 | 0.07 | Why? |
| Amino Acid Sequence | 4 | 2020 | 6049 | 0.07 | Why? |
| Vaccines, DNA | 3 | 2019 | 871 | 0.07 | Why? |
| Ubiquitin | 1 | 2006 | 243 | 0.07 | Why? |
| Epitopes, T-Lymphocyte | 2 | 2019 | 2262 | 0.07 | Why? |
| Double-Blind Method | 3 | 2021 | 5988 | 0.07 | Why? |
| Cloning, Molecular | 1 | 2007 | 1036 | 0.07 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 436 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Immunoglobulin G | 2 | 2018 | 21571 | 0.06 | Why? |
| HeLa Cells | 2 | 2017 | 1303 | 0.06 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Female | 9 | 2021 | 380317 | 0.06 | Why? |
| HLA-A Antigens | 2 | 2017 | 196 | 0.06 | Why? |
| Vaccines, Subunit | 2 | 2021 | 1088 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Protein Structure, Secondary | 2 | 2018 | 1077 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Tandem Repeat Sequences | 1 | 2021 | 78 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.05 | Why? |
| Sequence Alignment | 2 | 2020 | 2109 | 0.05 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.05 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Emulsions | 1 | 2020 | 80 | 0.05 | Why? |
| Immunization, Passive | 1 | 2016 | 10067 | 0.05 | Why? |
| Spodoptera | 1 | 2020 | 220 | 0.05 | Why? |
| Sf9 Cells | 1 | 2020 | 273 | 0.05 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2020 | 2134 | 0.05 | Why? |
| Alum Compounds | 1 | 2020 | 210 | 0.05 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2020 | 358 | 0.05 | Why? |
| Poxviridae Infections | 1 | 2019 | 31 | 0.05 | Why? |
| Peptide Hydrolases | 1 | 2007 | 1269 | 0.05 | Why? |
| Structural Homology, Protein | 1 | 2019 | 149 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.05 | Why? |
| Chemistry Techniques, Synthetic | 1 | 2018 | 60 | 0.05 | Why? |
| MAP Kinase Kinase 7 | 1 | 2017 | 19 | 0.04 | Why? |
| Swine | 2 | 2017 | 3352 | 0.04 | Why? |
| Pan troglodytes | 1 | 2018 | 157 | 0.04 | Why? |
| Transcription Factor AP-1 | 1 | 2017 | 75 | 0.04 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2017 | 191 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Molecular Conformation | 1 | 2018 | 374 | 0.04 | Why? |
| Transfection | 1 | 2020 | 864 | 0.04 | Why? |
| Chimera | 1 | 2016 | 83 | 0.04 | Why? |
| Parvovirus, Canine | 1 | 2016 | 86 | 0.04 | Why? |
| Vaccinia virus | 1 | 2019 | 346 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| Single-Chain Antibodies | 1 | 2018 | 259 | 0.04 | Why? |
| Poultry | 1 | 2017 | 437 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Ubiquitination | 1 | 2017 | 343 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2016 | 317 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.04 | Why? |
| Male | 6 | 2021 | 367725 | 0.04 | Why? |
| Mutation, Missense | 1 | 2021 | 863 | 0.04 | Why? |
| Horses | 1 | 2016 | 474 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.04 | Why? |
| Surface Plasmon Resonance | 1 | 2016 | 440 | 0.03 | Why? |
| Nucleocapsid Proteins | 1 | 2006 | 3120 | 0.03 | Why? |
| Ligands | 1 | 2019 | 1300 | 0.03 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.03 | Why? |
| Antiviral Agents | 4 | 2020 | 41703 | 0.03 | Why? |
| Capsid Proteins | 1 | 2016 | 365 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
| Host-Pathogen Interactions | 3 | 2018 | 11041 | 0.03 | Why? |
| Th2 Cells | 1 | 2016 | 680 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Membrane Fusion | 1 | 2017 | 713 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Receptors, Immunologic | 1 | 2016 | 555 | 0.03 | Why? |
| Immunodominant Epitopes | 1 | 2017 | 813 | 0.03 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.03 | Why? |
| Genetic Vectors | 1 | 2019 | 1600 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.03 | Why? |
| Erythrocytes | 1 | 2016 | 617 | 0.03 | Why? |
| Conserved Sequence | 1 | 2013 | 751 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2013 | 945 | 0.03 | Why? |
| Th1 Cells | 1 | 2016 | 1228 | 0.03 | Why? |
| Protein Interaction Maps | 1 | 2018 | 1333 | 0.03 | Why? |
| Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
| HLA-A2 Antigen | 1 | 2010 | 134 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2016 | 2219 | 0.02 | Why? |
| Viral Tropism | 1 | 2017 | 1329 | 0.02 | Why? |
| Protein Structure, Quaternary | 1 | 2010 | 455 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2014 | 3198 | 0.02 | Why? |
| Protein Structure, Tertiary | 1 | 2013 | 1565 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2019 | 5837 | 0.02 | Why? |
| Carrier Proteins | 1 | 2010 | 513 | 0.02 | Why? |
| Two-Hybrid System Techniques | 1 | 2006 | 116 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2010 | 12361 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Protein Conformation | 1 | 2016 | 4386 | 0.02 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Antibody Formation | 1 | 2017 | 4038 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| China | 2 | 2021 | 50654 | 0.01 | Why? |
| Drug Discovery | 1 | 2016 | 3092 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2016 | 6817 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Aged | 1 | 2017 | 215776 | 0.00 | Why? |
Yan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(210)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_